COMy 2019 | What is the future for myeloma clinical trials?

Mohamad Mohty

Mohamad Mohty, MD, PhD of Saint-Antoine Hospital, Paris, France, discusses the future of clinical trials for multiple myeloma, including a focus on smoldering myeloma and stopping the evolution of myeloma at an earlier stage, rather than after organ damage. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video